News Ekso Bionics Holdings, Inc.

Equities

EKSO

US2826443010

Delayed Nasdaq Other stock markets 02:24:38 2024-04-16 pm EDT			5-day change	1st Jan Change
1.3 ^USD	-9.72%		-3.70%	-48.00%

Mar. 17	Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	CI
Mar. 17	Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal	Apr. 12	AQ
Certain Warrants of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	Mar. 16	CI
Certain Common Stock of Ekso Bionics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 17-MAR-2024.	Mar. 16	CI
HC Wainwright Trims Price Target on Ekso Bionics to $9.25 From $10, Keeps Buy Rating	Mar. 05	MT
Transcript : Ekso Bionics Holdings, Inc., Q4 2023 Earnings Call, Mar 04, 2024	Mar. 04
Ekso Bionics: Q4 Earnings Snapshot	Mar. 04	AQ
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 04	CI
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 04	CI
Ekso Bionics Reports Record Annual Revenue of $18.3 Million	Mar. 04	AQ
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024	Feb. 26	AQ
HC Wainwright Adjusts Ekso Bionics Holdings' Price Target to $10 From $9, Keeps Buy Rating	Jan. 22	MT
Ekso Bionics Announces $4.6 Million Registered Direct Offering	Jan. 11	AQ
Ekso Bionics Launches GaitCoach Software for EksoNR	Jan. 08	AQ
Ekso Bionics Holdings, Inc. Launches GaitCoach Software for EksoNR	Jan. 08	CI
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results	Jan. 04	AQ
Ekso Bionics Holdings, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023	Jan. 04	CI
Ekso Bionics : Investor Presentation	Dec. 18	PU
Ekso Bionics Receives CMS Coding Approval for Ekso Indego Personal	Dec. 12	AQ
Ekso Bionics Holdings, Inc. Receives CMS Coding Approval for Ekso Indego Personal	Dec. 12	CI
Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29	Nov. 16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ekso Bionics Holdings, Inc.

Equities

EKSO

US2826443010

Summary

Filters